Jieting Xu

Jieting (Christine) Xu has a diverse work experience spanning over 15 years. Jieting (Christine) is currently working as the Executive Director of Finance at Brii Biosciences since November 2021. Prior to this, they held various roles at Novartis from 2009 to 2021, including China CFO of Sandoz division and Head of Business Planning & Analysis. Before that, they worked as an FP&A Analyst at GE Healthcare from 2008 to 2009 and participated in the Financial Management Program at GE from 2006 to 2008, where they gained experience in various finance roles.

Jieting (Christine) Xu completed their Bachelor's degree in Accounting at Sun Yat-sen University from 2000 to 2004. Jieting (Christine) then pursued a Master's degree in Finance at Lancaster University from 2004 to 2005.